U.S. market Closed. Opens in 7 hours 38 minutes

CTSO | Cytosorbents Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-05-31
Revenue36.35M29.36M40.11M39.45M22.77M20.25M15.15M9.53M4.79M4.12M2.42M1.34M36.08KN/AN/AN/AN/AN/A10.00K
Cost of Revenue13.96M13.96M11.05M11.05M7.36M7.49M5.52M3.95M2.21M2.13M1.91M319.30K11.76KN/AN/AN/AN/AN/A10.00K
Gross Profit22.39M15.40M29.06M28.40M15.40M12.76M9.63M5.57M2.58M1.99M511.10K1.02M24.32KN/AN/AN/AN/AN/AN/A
Operating Expenses52.95M46.93M51.81M38.77M34.38M28.35M19.47M17.07M11.88M9.27M5.22M4.51M4.46M2.82M3.03M3.24M3.07M2.96M80.00K
Selling, General & Admin33.60M37.14M38.48M31.51M24.47M22.88M15.43M12.28M8.01M6.84M3.49M1.98M1.57M1.07M1.07M1.26M1.65M1.85M70.00K
Research & Development15.73M15.12M16.38M8.81M12.09M7.72M4.05M4.78M3.87M2.43M1.74M2.53M2.89M1.76M1.96M1.98M1.42M1.11MN/A
Other Operating Expenses-3.62M-5.33M-3.06M-1.55M-2.18M-2.25MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A10.00K
Operating Income-30.55M-31.52M-22.75M-10.37M-18.97M-15.58M-9.84M-11.49M-9.30M-7.28M-4.71M-3.49M-4.44M-2.82M-3.03M-3.24M-3.07M-2.96M-80.00K
Other Expenses / Income1.23M-2.38M-2.55M1.41M-1.38M-784.75K705.06K-765.30K847.32K-2.43M-422.84K-564.43K-1.04M5.73M6.06M-22.21K-351.49K31.61KN/A
Before Tax Income-29.32M-33.91M-25.30M-8.96M-20.36M-17.83M-9.14M-12.26M-8.46M-9.71M-5.14M-4.06M-5.48M2.91M3.04M-3.27MN/AN/A-80.00K
Income Tax Expenses-813.74K-1.09M-736.00K-1.13M-1.09M-619.55K-676.74K-318.55K-324.61K-385.64K-458.28K-391.76KN/AN/A298.79K-248.53KN/AN/AN/A
Net Income-28.51M-32.81M-24.56M-7.84M-19.27M-17.21M-8.46M-11.94M-8.13M-9.32M-4.68M-3.66M-5.48M-2.91M-2.74M-3.02M-3.35M-7.67M-80.00K
Interest Expenses157.89K132.60KN/A1.20M1.03M1.46MN/AN/A9.30K310.02K422.84K564.43K1.04M84.85K8.14K22.21KN/A4.74MN/A
Basic Shares Outstanding44.66M43.57M43.36M38.82M32.26M30.72M27.61M25.43M24.89M14.38M9.44M7.93M6.41M3.92M1.66M1.00M993.94K598.24K310.00K
Diluted Shares Outstanding44.66M43.57M43.36M38.82M32.26M30.72M27.61M25.43M24.89M14.38M9.44M7.93M6.41M3.92M1.66M1.00M993.94K598.24K310.00K
EBITDA-28.53M-29.07M-20.17M-10.37M-18.97M-15.19M-8.92M-12.10M-8.33M-9.33M-4.65M-3.44M-4.40M-2.81M-2.98M-3.14M-2.88M-1.74M-70.00K
EBITDA Margin-78.48%-99.02%-50.28%-26.28%-83.34%-75.03%-58.87%-126.95%-173.93%-226.34%-191.89%-255.87%-12,189.19%0.00%0.00%0.00%0.00%0.00%-700.00%
EBIT-29.16M-33.77M-25.30M-7.76M-19.32M-16.37M-9.14M-12.26M-8.45M-9.40M-4.71M-3.49M-4.44M-2.82M-2.43M-3.24M-3.35M-2.93M-80.00K
EBIT Margin-80.23%-115.03%-63.07%-19.68%-84.88%-80.83%-60.31%-128.65%-176.29%-227.93%-194.55%-259.94%-12,297.71%0.00%0.00%0.00%0.00%0.00%-800.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-05-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙